Insiders Updates
Lexaria Bioscience Corp’s latest rating changes from various analysts
Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25.
Menu
Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25.
The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or
Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Lexaria Bioscience
Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25.
Lexaria Bioscience Corp’s filing revealed that its Director BUNKA CHRISTOPHER acquired Company’s shares for reported $14375.0 on Jul 29 ’25.